These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28964258)

  • 41. Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization.
    Boonyalai N; Vesely BA; Thamnurak C; Praditpol C; Fagnark W; Kirativanich K; Saingam P; Chaisatit C; Lertsethtakarn P; Gosi P; Kuntawunginn W; Vanachayangkul P; Spring MD; Fukuda MM; Lon C; Smith PL; Waters NC; Saunders DL; Wojnarski M
    Malar J; 2020 Jul; 19(1):269. PubMed ID: 32711538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in Thailand.
    Auburn S; Serre D; Pearson RD; Amato R; Sriprawat K; To S; Handayuni I; Suwanarusk R; Russell B; Drury E; Stalker J; Miotto O; Kwiatkowski DP; Nosten F; Price RN
    J Infect Dis; 2016 Oct; 214(8):1235-42. PubMed ID: 27456706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreasing pfmdr1 copy number suggests that Plasmodium falciparum in Western Cambodia is regaining in vitro susceptibility to mefloquine.
    Lim P; Dek D; Try V; Sreng S; Suon S; Fairhurst RM
    Antimicrob Agents Chemother; 2015 May; 59(5):2934-7. PubMed ID: 25712365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Wirjanata G; Sebayang B; Piera KA; Wittlin S; Haynes RK; Möhrle JJ; Anstey NM; Kenangalem E; Price RN
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5258-63. PubMed ID: 22850522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of mefloquine use on Plasmodium vivax multidrug resistance.
    Khim N; Andrianaranjaka V; Popovici J; Kim S; Ratsimbasoa A; Benedet C; Barnadas C; Durand R; Thellier M; Legrand E; Musset L; Menegon M; Severini C; Nour BY; Tichit M; Bouchier C; Mercereau-Puijalon O; Ménard D
    Emerg Infect Dis; 2014 Oct; 20(10):1637-44. PubMed ID: 25272023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.
    Lim P; Chim P; Sem R; Nemh S; Poravuth Y; Lim C; Seila S; Tsuyuoka R; Denis MB; Socheat D; Fandeur T
    Acta Trop; 2005 Jan; 93(1):31-40. PubMed ID: 15589795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia.
    Chaorattanakawee S; Lanteri CA; Sundrakes S; Yingyuen K; Gosi P; Chanarat N; Wongarunkochakorn S; Buathong N; Chann S; Kuntawunginn W; Arsanok M; Lin JT; Juliano JJ; Tyner SD; Char M; Lon C; Saunders DL
    Malar J; 2015 Dec; 14():486. PubMed ID: 26626127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.
    Fernández D; Segura C; Arboleda M; Garavito G; Blair S; Pabón A
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6354-9. PubMed ID: 25114141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso.
    Tahita MC; Tinto H; Yarga S; Kazienga A; Traore Coulibaly M; Valea I; Van Overmeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Erhart A; D'Alessandro U
    Malar J; 2015 Jun; 14():251. PubMed ID: 26088768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic diversity of Plasmodium vivax metacaspase 1 and Plasmodium vivax multi-drug resistance 1 genes of field isolates from Mauritania, Sudan and Oman.
    Sow F; Bonnot G; Ahmed BR; Diagana SM; Kebe H; Koita M; Samba BM; Al-Mukhaini SK; Al-Zadjali M; Al-Abri SS; Ali OA; Samy AM; Hamid MM; Ali Albsheer MM; Simon B; Bienvenu AL; Petersen E; Picot S
    Malar J; 2017 Feb; 16(1):61. PubMed ID: 28153009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs.
    Foguim FT; Robert MG; Gueye MW; Gendrot M; Diawara S; Mosnier J; Amalvict R; Benoit N; Bercion R; Fall B; Madamet M; Pradines B;
    Malar J; 2019 Aug; 18(1):293. PubMed ID: 31455301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic diversity of the Plasmodium vivax multidrug resistance 1 gene in Thai parasite populations.
    Kittichai V; Nguitragool W; Ngassa Mbenda HG; Sattabongkot J; Cui L
    Infect Genet Evol; 2018 Oct; 64():168-177. PubMed ID: 29936038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
    Price RN; Marfurt J; Chalfein F; Kenangalem E; Piera KA; Tjitra E; Anstey NM; Russell B
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5146-50. PubMed ID: 20876370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surveillance of drug resistance molecular markers in Plasmodium vivax before and after introduction of dihydroartemisinin and piperaquine in Thailand: 2009-2019.
    Suphakhonchuwong N; Rungsihirunrat K; Kuesap J
    Parasitol Res; 2023 Dec; 122(12):2871-2883. PubMed ID: 37725258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination.
    Phompradit P; Muhamad P; Chaijaroenkul W; Na-Bangchang K
    Acta Trop; 2014 Nov; 139():77-83. PubMed ID: 25004442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorphism of the parasite lactate dehydrogenase gene from Plasmodium vivax Korean isolates.
    Shin HI; Kim JY; Lee WJ; Sohn Y; Lee SW; Kang YJ; Lee HW
    Malar J; 2013 May; 12():166. PubMed ID: 23688062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chloroquine resistance is associated to multi-copy pvcrt-o gene in Plasmodium vivax malaria in the Brazilian Amazon.
    Silva SR; Almeida ACG; da Silva GAV; Ramasawmy R; Lopes SCP; Siqueira AM; Costa GL; Sousa TN; Vieira JLF; Lacerda MVG; Monteiro WM; de Melo GC
    Malar J; 2018 Jul; 17(1):267. PubMed ID: 30012145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.
    Mukherjee A; Bopp S; Magistrado P; Wong W; Daniels R; Demas A; Schaffner S; Amaratunga C; Lim P; Dhorda M; Miotto O; Woodrow C; Ashley EA; Dondorp AM; White NJ; Wirth D; Fairhurst R; Volkman SK
    Malar J; 2017 May; 16(1):195. PubMed ID: 28494763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.
    Htun MW; Mon NCN; Aye KM; Hlaing CM; Kyaw MP; Handayuni I; Trimarsanto H; Bustos D; Ringwald P; Price RN; Auburn S; Thriemer K
    Malar J; 2017 Jul; 16(1):281. PubMed ID: 28693552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.